QR Kod

TLR9 and STING agonists adjuvanted varicella-zoster virus glycoprotein E induced a potent and durable nasal vaccine response

Herpes zoster is caused by the reactivation of latent varicella-zoster virus (VZV), primarily affecting middle-aged and older individuals and often accompanied by severe pain and other complications. Vaccination is an effective preventive measure against this disease. In the present study, we evalua...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: Jing-Xing Yang, Po-Yen Lin, Jen-Chih Tseng, Zaida Nur Imana, Yi-Ling Liu, Chih-Feng Tien, Yu-Siang Su, Wan-Ting Tsai, Yu-Wen Su, Jen-Kun Chen, Ming-Hsi Huang, Linyi Chen, Tsung-Hsien Chuang, Guann-Yi Yu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Taylor & Francis Group 2026-12-01
Seri Bilgileri:Human Vaccines & Immunotherapeutics
Konular:
Adjuvant
CpG-containing oligodeoxynucleotides
cyclic dinucleotide
herpes zoster
vaccine
Online Erişim:https://www.tandfonline.com/doi/10.1080/21645515.2026.2615532
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller